Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Micro-robots clear sinus infections without antibiotics Navigate sinuses using magnets and heat-activated action Showed ...

An immunocompromised woman’s cat stirred up a lot more trouble than usual (for a cat). In a recent case report, doctors ...

New research identifies key genes in "zombie" TB cells resistant to antibiotics, bringing new drugs one step closer.

Anaerobic bacteria were among the first life forms on Earth and existed at a time when there was no oxygen in the atmosphere.

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Bacteria are ubiquitous microscopic organisms capable of rapid growth. While beneficial strains like lactic acid bacteria (LAB) promote gut health and ...

Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an ...

In the study, the Surrey team exposed a vast library of over 500,000 genetically modified TB bacteria to two commonly used antibiotics – rifampicin and streptomycin. The exposure was extended long ...